Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
1(11%)
Results Posted
40%(2 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_1
1
11%
Ph phase_4
1
11%
Ph not_applicable
7
78%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(5)
Terminated(1)
Other(2)

Detailed Status

Completed5
unknown2
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 41 (11.1%)
N/A7 (77.8%)

Trials by Status

completed556%
recruiting111%
terminated111%
unknown222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
PROCEDURE
Total Trials
9